MyAlcon | Sweden

This page is available in English. Please click below for other countries.

Other Country

Complete Confidence:
The Alcon Advantage

IOL Options for Every Patient


Complete Confidence: The Alcon Advantage


IOL Options for Every Patient



AcrySof IQ Vivity™ IOL


The first and only presbyopia-correcting IOL with wavefront-shaping technology.1-4

A close-up shot of a car’s left passenger side headlight illuminating the dark. A vertical line divides the headlight in two, with a starburst effect on the light on the left side of the line.

Clareon™ PanOptix™ IOL


PanOptix™ delivers an exceptional high-quality visual experience from far to near, with 99% patient satisfaction and over 2.2 million implants worldwide.5-9

A picture of a hand holding a gold medal. Gold laurels and a caduceus appear on the medal.

AcrySof™ IQ Monofocal IOL and AcrySof™ IQ Toric IOL


The trusted IOLs that give you confidence.10

An image of printed research papers placed on the ground in such a way that the borders of the papers create the outline of an IOL. An iPad lies on top of the papers, displaying a title page to a study on the AcrySof IQ platform. A blue medical mask lies next to the iPad. This all appears on a grey background.

Clareon™ Monofocal IOL and Clareon™ Toric IOL


Our most advanced lens design that delivers pristine visual outcomes.10-12

A close-up image of two intraocular lenses overlaid with a blue background.

Alcon Experience Academy


For relevant training content from industry thought leaders

1. AcrySof IQ Vivity™ Extended Vision IOL Directions for Use.
2. Alcon Data on File. US Patent 9968440 B2. 15 May 2018.
3. Alcon Data on File. TDOC-0055575. 09 Apr 2019.
4. Alcon Data on File. TDOC-0055576. 09 Apr 2019.
5. Modi S, et al. Visual and patient-reported outcomes of a diffractive trifocal intraocular lens compared with those of a monofocal intraocular lens. Ophthalmology. 2021;128(2):197-207.
6. Zhu et al. Rate of Complete Spectacle Independence with a Trifocal IOL (PanOptix): A Systematic Literature Review and Meta-Analysis. Presentation at 2022 ASCRS; April 2022; Washington, D.C.
7. Market Scope 2022 IOL Market Report.
8. Alcon Data on File, 2022. [REF-18881].
9. Clareon™ PanOptix™ Trifocal IOL Directions for Use.
10. Clareon™ IOL Directions for use.
11. Werner L, Thatthamla I, Ong M, et al. Evaluation of clarity characteristics in a new hydrophobic acrylic IOL in comparison to commercially available IOLs. J Cataract Refract Surg. 2019;45(10):1490-1497.
12. Oshika T, Fujita Y, Inamura M, Miyata K. Mid-term and long-term clinical assessments of a new 1-piece hydrophobic acrylic IOL with hydroxyethyl methacrylate. J Cataract Refract Surg. 2020;46(5):682-687.


Medical Devices manufactured by Alcon comply with all applicable laws and regulations. For indications, contraindications, warnings and serious incidents please refer to the relevant product’s direction for use or operator manuals.

1. Strictly Necessary Cookies 2. Functional Cookies 3. Targeting Cookies 4. Performance Cookies. 5. Social Media Cookies

Close 1. Strictly Necessary Cookies Close 2. Functional Cookies Close 3. Targeting Cookies. Close 4. Performance Cookies. Close. 5. Social Media Cookies